Featured Research

from universities, journals, and other organizations

New technique uses ATP as trigger for targeted anti-cancer drug delivery

Date:
March 11, 2014
Source:
North Carolina State University
Summary:
A new technique that uses adenosine-5'-triphosphate, the so-called 'energy molecule,' to trigger the release of anti-cancer drugs directly into cancer cells has been developed by biomedical engineering researchers. Early laboratory tests show it increases the effectiveness of drugs targeting breast cancer.

The nanoparticles are packed with DNA molecules that are embedded with an anti-cancer drug called doxorubicin.
Credit: Ran Mo

Biomedical engineering researchers have developed a new technique that uses adenosine-5'-triphosphate (ATP), the so-called "energy molecule," to trigger the release of anti-cancer drugs directly into cancer cells. Early laboratory tests show it increases the effectiveness of drugs targeting breast cancer. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.

"This is a proof of concept, but we've demonstrated there is now a new tool for introducing anti-cancer drugs directly into cancer cells -- and that should make drug treatments significantly more effective," says Dr. Zhen Gu, senior author of a paper on the research and an assistant professor in the joint biomedical engineering program at NC State and UNC-Chapel Hill.

Gu's research team developed spherical nanoparticles coated with a shell that incorporates hyaluronic acid (HA), which interacts with proteins found on the surface of some cancer cells. When a targeted cancer cell comes into contact with the HA, the cell absorbs the entire nanoparticle.

Once inside the cancer cell, the nanoparticle's shell comes apart, releasing its payload: a collection of complex DNA molecules that are embedded with an anti-cancer drug called doxorubicin (Dox), which targets the nucleus of the cancer cell.

The DNA molecules are designed to unfold -- and release the Dox -- only when they come into contact with high ATP levels. High levels of ATP are normally only found inside a cell, which means the Dox is released within striking distance of the nucleus -- and not inadvertently released outside the cell.

"This is the first time ATP has been used as a molecular trigger for controlled release of anti-cancer drugs, both in vitro and in vivo," says Dr. Ran Mo, lead author of the paper and a postdoctoral researcher in the joint biomedical engineering program. ATP transports chemical energy within cells for metabolism.

In in vitro testing, the new technique was 3.6 times more effective against MDA-MB-231 human breast cancer cells than techniques that don't incorporate an ATP-targeting component.

The researchers also tested the new technique in an in vivo model, using mice that had breast cancer tumors. The researchers found that the ATP-targeting technique was significantly more effective at inhibiting tumor growth compared with other techniques.

"We also believe that we'll be able to make the technique even more targeted by manipulating ATP levels in specific areas," Gu says.


Story Source:

The above story is based on materials provided by North Carolina State University. The original article was written by Matt Shipman. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ran Mo, Tianyue Jiang, Rocco DiSanto, Wanyi Tai, Zhen Gu. ATP-triggered anticancer drug delivery. Nature Communications, 2014; 5 DOI: 10.1038/ncomms4364

Cite This Page:

North Carolina State University. "New technique uses ATP as trigger for targeted anti-cancer drug delivery." ScienceDaily. ScienceDaily, 11 March 2014. <www.sciencedaily.com/releases/2014/03/140311124200.htm>.
North Carolina State University. (2014, March 11). New technique uses ATP as trigger for targeted anti-cancer drug delivery. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/03/140311124200.htm
North Carolina State University. "New technique uses ATP as trigger for targeted anti-cancer drug delivery." ScienceDaily. www.sciencedaily.com/releases/2014/03/140311124200.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins